Reuters logo
BRIEF-Intellia Therapeutics reports qtrly loss per share of $0.36
2017年5月2日 / 中午12点23分 / 7 个月前

BRIEF-Intellia Therapeutics reports qtrly loss per share of $0.36

May 2 (Reuters) - Intellia Therapeutics Inc :

* Intellia Therapeutics announces first quarter 2017 financial results

* Q1 collaboration revenue $6.2 million

* Qtrly loss per share $0.36

* Cash and cash equivalents at march 31, 2017, were $258 million, compared to $64 million for same quarter in 2016

* During 2017, co expects expenses to continue to increase compared to prior periods Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below